FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039526089> ?p ?o ?g. }

• W3039526089 endingPage "604.e5" @default.
• W3039526089 startingPage "597" @default.
• W3039526089 abstract "Background and Aims EUS-guided biopsy sampling is the method of choice for obtaining pancreatic tissue. Next-generation sequencing (NGS) has been applied to EUS-guided biopsy sampling and may classify patients based on specific molecular profiles. Our study aimed to compare side-by-side the diagnostic yield achievable by genetic identification of somatic mutations detected with NGS versus histologic and cytologic typing in locally advanced pancreatic carcinoma (LAPC) in samples acquired under EUS guidance. Methods We conducted a prospective comparative pilot study at Humanitas Research Hospital. The study included 33 patients referred for LAPC who underwent EUS-guided tissue acquisition using a 22-gauge Franseen needle. Material was obtained for both pathologic diagnosis and DNA extraction and targeted NGS analysis with the AmpliSeq Comprehensive Panel v3 (Illumina Inc, San Diego, Calif, USA). Twenty-one genes were prioritized for somatic mutation detection. Results The final diagnosis was pancreatic ductal adenocarcinoma (PDAC) in all patients (100%). A macroscopic core was obtained in 30 patients (91%). In 3 lesions no cores adequate for histologic analysis were obtained, but cytologic analysis revealed tumoral cells from PDAC. DNA was extracted from 32 of 33 samples (97%), most of which (27/32) carried at least 2 clearly pathogenic mutations in different genes. Detection of K-ras mutation allowed for molecular diagnosis of PDAC in most of the patients (30/32). Conclusions In our study we demonstrated that proper tissue specimens obtained under EUS guidance allowed DNA sample extraction and subsequent NGS analysis in 97% of cases. These results support the potential role of NGS as a complementary diagnostic test to be implemented in association with standard diagnostic modalities. (Clinical trial registration number: NCT03578939.) EUS-guided biopsy sampling is the method of choice for obtaining pancreatic tissue. Next-generation sequencing (NGS) has been applied to EUS-guided biopsy sampling and may classify patients based on specific molecular profiles. Our study aimed to compare side-by-side the diagnostic yield achievable by genetic identification of somatic mutations detected with NGS versus histologic and cytologic typing in locally advanced pancreatic carcinoma (LAPC) in samples acquired under EUS guidance. We conducted a prospective comparative pilot study at Humanitas Research Hospital. The study included 33 patients referred for LAPC who underwent EUS-guided tissue acquisition using a 22-gauge Franseen needle. Material was obtained for both pathologic diagnosis and DNA extraction and targeted NGS analysis with the AmpliSeq Comprehensive Panel v3 (Illumina Inc, San Diego, Calif, USA). Twenty-one genes were prioritized for somatic mutation detection. The final diagnosis was pancreatic ductal adenocarcinoma (PDAC) in all patients (100%). A macroscopic core was obtained in 30 patients (91%). In 3 lesions no cores adequate for histologic analysis were obtained, but cytologic analysis revealed tumoral cells from PDAC. DNA was extracted from 32 of 33 samples (97%), most of which (27/32) carried at least 2 clearly pathogenic mutations in different genes. Detection of K-ras mutation allowed for molecular diagnosis of PDAC in most of the patients (30/32). In our study we demonstrated that proper tissue specimens obtained under EUS guidance allowed DNA sample extraction and subsequent NGS analysis in 97% of cases. These results support the potential role of NGS as a complementary diagnostic test to be implemented in association with standard diagnostic modalities. (Clinical trial registration number: NCT03578939.)" @default.
• W3039526089 created "2020-07-10" @default.
• W3039526089 creator A5008608270 @default.
• W3039526089 creator A5014197864 @default.
• W3039526089 creator A5018522403 @default.
• W3039526089 creator A5020927144 @default.
• W3039526089 creator A5046188281 @default.
• W3039526089 creator A5048645120 @default.
• W3039526089 creator A5051867363 @default.
• W3039526089 creator A5061290127 @default.
• W3039526089 creator A5071261627 @default.
• W3039526089 creator A5073627212 @default.
• W3039526089 creator A5076496892 @default.
• W3039526089 creator A5081807978 @default.
• W3039526089 creator A5087162627 @default.
• W3039526089 creator A5087478030 @default.
• W3039526089 date "2021-03-01" @default.
• W3039526089 modified "2023-10-07" @default.
• W3039526089 title "Side-by-side comparison of next-generation sequencing, cytology, and histology in diagnosing locally advanced pancreatic adenocarcinoma" @default.
• W3039526089 cites W1987313243 @default.
• W3039526089 cites W2167151455 @default.
• W3039526089 cites W2297506157 @default.
• W3039526089 cites W2406561168 @default.
• W3039526089 cites W2605033390 @default.
• W3039526089 cites W2614139584 @default.
• W3039526089 cites W2743061229 @default.
• W3039526089 cites W2793938850 @default.
• W3039526089 cites W2909133144 @default.
• W3039526089 cites W2911188335 @default.
• W3039526089 cites W2938542029 @default.
• W3039526089 cites W2940577141 @default.
• W3039526089 cites W2943426452 @default.
• W3039526089 cites W2944347350 @default.
• W3039526089 cites W2953066952 @default.
• W3039526089 cites W2955423580 @default.
• W3039526089 cites W2964025821 @default.
• W3039526089 cites W2974938967 @default.
• W3039526089 cites W2978962369 @default.
• W3039526089 cites W3013469238 @default.
• W3039526089 doi "https://doi.org/10.1016/j.gie.2020.06.069" @default.
• W3039526089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32640200" @default.
• W3039526089 hasPublicationYear "2021" @default.
• W3039526089 type Work @default.
• W3039526089 sameAs 3039526089 @default.
• W3039526089 citedByCount "18" @default.
• W3039526089 countsByYear W30395260892020 @default.
• W3039526089 countsByYear W30395260892021 @default.
• W3039526089 countsByYear W30395260892022 @default.
• W3039526089 countsByYear W30395260892023 @default.
• W3039526089 crossrefType "journal-article" @default.
• W3039526089 hasAuthorship W3039526089A5008608270 @default.
• W3039526089 hasAuthorship W3039526089A5014197864 @default.
• W3039526089 hasAuthorship W3039526089A5018522403 @default.
• W3039526089 hasAuthorship W3039526089A5020927144 @default.
• W3039526089 hasAuthorship W3039526089A5046188281 @default.
• W3039526089 hasAuthorship W3039526089A5048645120 @default.
• W3039526089 hasAuthorship W3039526089A5051867363 @default.
• W3039526089 hasAuthorship W3039526089A5061290127 @default.
• W3039526089 hasAuthorship W3039526089A5071261627 @default.
• W3039526089 hasAuthorship W3039526089A5073627212 @default.
• W3039526089 hasAuthorship W3039526089A5076496892 @default.
• W3039526089 hasAuthorship W3039526089A5081807978 @default.
• W3039526089 hasAuthorship W3039526089A5087162627 @default.
• W3039526089 hasAuthorship W3039526089A5087478030 @default.
• W3039526089 hasConcept C104317684 @default.
• W3039526089 hasConcept C106131492 @default.
• W3039526089 hasConcept C121608353 @default.
• W3039526089 hasConcept C126322002 @default.
• W3039526089 hasConcept C126838900 @default.
• W3039526089 hasConcept C140779682 @default.
• W3039526089 hasConcept C142724271 @default.
• W3039526089 hasConcept C176944494 @default.
• W3039526089 hasConcept C18823058 @default.
• W3039526089 hasConcept C2775934546 @default.
• W3039526089 hasConcept C2780210213 @default.
• W3039526089 hasConcept C2781182431 @default.
• W3039526089 hasConcept C2992026798 @default.
• W3039526089 hasConcept C3019914693 @default.
• W3039526089 hasConcept C31972630 @default.
• W3039526089 hasConcept C41008148 @default.
• W3039526089 hasConcept C501734568 @default.
• W3039526089 hasConcept C50524450 @default.
• W3039526089 hasConcept C51679486 @default.
• W3039526089 hasConcept C530470458 @default.
• W3039526089 hasConcept C54355233 @default.
• W3039526089 hasConcept C57742111 @default.
• W3039526089 hasConcept C71924100 @default.
• W3039526089 hasConcept C86803240 @default.
• W3039526089 hasConceptScore W3039526089C104317684 @default.
• W3039526089 hasConceptScore W3039526089C106131492 @default.
• W3039526089 hasConceptScore W3039526089C121608353 @default.
• W3039526089 hasConceptScore W3039526089C126322002 @default.
• W3039526089 hasConceptScore W3039526089C126838900 @default.
• W3039526089 hasConceptScore W3039526089C140779682 @default.
• W3039526089 hasConceptScore W3039526089C142724271 @default.
• W3039526089 hasConceptScore W3039526089C176944494 @default.
• W3039526089 hasConceptScore W3039526089C18823058 @default.
• W3039526089 hasConceptScore W3039526089C2775934546 @default.

• next